To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity. Canadian Diabetes & Endocrinology Today, [S. l.], v. 4, n. 1, p. 26–34, 2026. DOI: 10.58931/cdet.2026.4152. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Khan. Acesso em: 26 mai. 2026.